Mesoblast
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.About MESO
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.
CEOSilviu Itescu
CEOSilviu Itescu
Employees81
Employees81
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded2004
Founded2004
Employees81
Employees81
MESO Key Statistics
Market cap2.30B
Market cap2.30B
Price-Earnings ratio-21.36
Price-Earnings ratio-21.36
Dividend yield—
Dividend yield—
Average volume238.46K
Average volume238.46K
High today$18.13
High today$18.13
Low today$17.48
Low today$17.48
Open price$18.13
Open price$18.13
Volume55.53K
Volume55.53K
52 Week high$22.00
52 Week high$22.00
52 Week low$9.61
52 Week low$9.61
Stock Snapshot
Mesoblast(MESO) stock is priced at $17.62, giving the company a market capitalization of 2.3B. It carries a P/E multiple of -21.36.
During the trading session on 2025-12-15, Mesoblast(MESO) shares reached a daily high of $18.13 and a low of $17.48. At a current price of $17.62, the stock is +0.8% higher than the low and still -2.8% under the high.
Trading volume for Mesoblast(MESO) stock has reached 55.53K, versus its average volume of 238.46K.
Over the past 52 weeks, Mesoblast(MESO) stock has traded between a high of $22.00 and a low of $9.61.
Over the past 52 weeks, Mesoblast(MESO) stock has traded between a high of $22.00 and a low of $9.61.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%